Lipoprotein(a)

What it actually measures

Lipoprotein(a) is an LDL particle with something extra bolted on.

Take a standard LDL particle, complete with its single apoB molecule, and attach a second protein called apolipoprotein(a) to it. That is Lp(a), and the addition changes its behaviour.

The extra protein happens to resemble plasminogen, a molecule involved in breaking down clots. That structural similarity is one of the proposed reasons Lp(a) contributes to risk through more than one route, potentially affecting both plaque formation and clotting.

Here is the part that makes this marker different from almost everything else on this site. Your Lp(a) concentration is largely determined by the gene you inherited, and it is remarkably stable across your adult life.

It does not meaningfully respond to diet. It does not respond much to exercise. Statins do not lower it and may slightly raise it.

Which sounds like a reason not to measure it, and is actually the opposite.

Why measure something you cannot change

The objection writes itself: why should I measure Lp(a) if I cannot lower it?

The European Atherosclerosis Society published a consensus statement on Lp(a) in 2022, and a 2023 follow-up in Atherosclerosis addressed 30 of the most frequently asked questions arising from it. That objection was one they answered directly.

The consensus summarised current knowledge on Lp(a) as causally associated with atherosclerotic cardiovascular disease and aortic stenosis, and introduced a risk calculator showing how Lp(a) influences lifetime risk, and that global risk may be substantially underestimated in individuals with high or very high concentrations.

That is the answer. Knowing your Lp(a) does not give you a lever to pull on Lp(a) itself. It tells you how hard to pull every other lever.

If your Lp(a) is high, your lifetime cardiovascular risk is higher than a standard calculator suggests, which changes how aggressively blood pressure, apoB, blood sugar and smoking should be managed. The consensus statement provides practical advice on exactly that: using Lp(a) knowledge to modulate risk factor management.

It also matters for your family. Because it is genetically determined, a high result is information about your children and siblings, and it is a reasonable prompt for them to be tested.

And the therapeutic picture is changing. The 2023 paper noted that specific and highly effective mRNA-targeted Lp(a)-lowering therapies are in clinical development, which makes knowing your number now more useful rather than less.

What moves it

Down: very little, honestly, and that is the defining feature of this marker. It does not respond meaningfully to diet, exercise or weight loss. Statins do not lower it. Some conditions lower it, including liver disease. Specific Lp(a)-lowering therapies are in clinical development rather than routinely available.

Up: genetics, which is the overwhelming determinant. Kidney disease raises it. Hypothyroidism raises it, which is one of the few reversible contributors worth checking. Postmenopausal status is associated with higher levels.

The honest hedge

I am not a doctor and I am not diagnosing anyone.

The most common mistake with this marker runs in the direction of despair rather than overconfidence. Someone gets a high result, learns it is genetic and largely unmodifiable, and concludes there is nothing to do.

That is exactly backwards. A high Lp(a) is a reason to be more rigorous about everything that is modifiable, because your baseline risk is higher and the other levers still work normally.

There is a measurement point worth knowing. Lp(a) can be reported either as a mass concentration in mg/dL or as a particle concentration in nmol/L, and the two are not interchangeable by a simple conversion factor because particle size varies genetically. Note which unit your result uses.

Testing is also underused for a specific structural reason: it is not on a standard lipid panel, there has been no specific drug to prescribe for it, and tests without treatments tend not to get ordered. That is changing.

This one belongs in a conversation with a doctor rather than being interpreted alone, particularly since a high result reasonably prompts family testing.

So. What to actually do.

Tonight, at no cost. Check whether anyone in your family had early cardiovascular disease, meaning before about 55 in men or 65 in women. That history is one of the strongest reasons to test this.

Ask for it once. Because it is genetically determined and stable across adult life, a single measurement is generally enough. This is unusual among the markers here and it makes the test unusually good value.

Note which unit your result uses. mg/dL and nmol/L are not interchangeable by a simple conversion, so comparing across labs needs care.

If it is high, tighten everything else. ApoB, blood pressure, inflammation, blood sugar and smoking all still respond normally, and a raised baseline is a reason to work them harder rather than to give up.

Check thyroid, since it is the reversible contributor. A thyroid panel is worth having in this picture.

Tell your family. A high result is genuinely information about your siblings and children, and it is a reasonable prompt for them to be tested.

Take it to a doctor rather than reading it alone. This is a risk conversation rather than a number to act on solo.

You are not doomed by a gene you did not choose. You are someone who now knows the size of the hill, which is exactly the information that tells you how hard to climb.

Your body is not broken. It is blocked. And in this case the block is inherited and permanent, which makes every unblocked path matter more rather than less.

Go find out whether anyone in your family had it early.